BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Nov 24, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Adderall XR: Post-marketing study data

Researchers at NIH and Duke University Medical Center published in Journal of the American Academy of Child and Adolescent Psychiatry that 2 classes of ADHD drugs - methylphenidate or mixed amphetamine salts - produced no significant increases from baseline in...

Read the full 179 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >